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Is Now the Time?*Mehdi H. Shishehbor, DO, MPH, PHD, Shikhar Agarwal, MD, MPHSEE PAGE 1893P eripheral artery disease (PAD) has been associ-ated with reduced survival in addition toincreased morbidity including amputation,
decreased quality of life, and immobility (1). Endo-
vascular revascularization has emerged as an attrac-
tive alternative to surgical revascularization for the
treatment of patients with PAD, especially for those
with critical limb ischemia (2,3). Indeed, data from a
nationwide inpatient sample demonstrated a marked
increase in endovascular revascularization in the past
decade, which has been temporally associated with a
reduction in the rates of major amputation (4). How-
ever, endovascular therapy encompasses a number
of tools and approaches (balloons, self-expanding
stents, balloon-expandable stents, covered stents,
and atherectomy, among others), without a clear al-
gorithm in many instances. Furthermore, unlike sur-
gery, which is mainly performed by one specialty
(i.e., vascular surgery), endovascular treatment is
offered by interventional radiologists, cardiologists,
vascular surgeons, and vascular medicine specialists,
with varying degrees of skill sets and biases. Because
of these facts, frequently, there is a lack of clear
consensus regarding the best treatment option,
approach, or device selection in treating PAD. Concor-
dant with this is the current treatment of severe
aortoiliac disease. The TransAtlantic Inter-Society
Consensus (TASC) II guidelines, in general, recom-
mend the endovascular approach for TASC A and B
and the surgical approach for TASC C and D lesions.
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apy for the majority of aortoiliac lesions, regardless
of TASC classiﬁcation (5,6). Although many factors
should be considered when deciding the best treat-
ment for aortoiliac disease, patency remains an
important endpoint. To that end, in this issue
of JACC: Cardiovascular Interventions, Kumakura
et al. (7) report 15-year survival and patency after pri-
mary stenting of TASC A through D iliac artery lesions
guided by intravascular ultrasound (IVUS).In this single-center study spanning June 1993 to
December 2013 with 455 patients, the authors
demonstrated the safety and efﬁcacy of performing
primary stenting in lower extremity vasculature
guided by IVUS (7). The authors must be compli-
mented on a high overall initial success rate with
primary stenting (97.2%), although the initial success
rate for complex TASC II type D lesions was slightly
lower (91.1%). There are several notable ﬁndings re-
ported in the paper. First, overall 15-year primary
patency was acceptable, but more important, no sig-
niﬁcant differences in primary patency were seen
among TASC classiﬁcations. Therefore, despite high
complexity at the time of intervention, successful
therapy, regardless of severity, yielded similar
patency. However, this ﬁnding, although important,
may be limited due to issues of power and relatively
small sample sizes in TASC C and D, especially over
the course of 15 years. Second, post-procedural
luminal area, measured by IVUS, was predictive of
short- and long-term patency, highlighting the clin-
ical utility of adjunctive imaging when performing
lower extremity endovascular interventions. Third,
the overall long-term survival among patients un-
dergoing aortoiliac interventions was poor, empha-
sizing the continuous need for more aggressive risk
factor and lifestyle modiﬁcation in these patients.
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1903Last, discontinuation of antiplatelet therapy was
associated with lower primary patency.
The study cohort was largely male dominated
(88%) and included mainly elderly patients with
mean age of 72 years. The reported incidence of crit-
ical limb ischemia was rather low (11.6%) in the
cohort, which might account for the higher initial
success rates and higher long-term patency rates.
Furthermore, 203 patients were excluded because
they underwent angioplasty alone. However, the
reason for angioplasty alone in these patients is not
reported, and this exclusion may have resulted in
signiﬁcant selection bias. More important, assess-
ment of patency was not adjudicated and was
assessed by various tools and differing time intervals.
For example, a signiﬁcant portion of patients under-
went resting ankle brachial index assessment during
follow-up for primary patency assessment. However,
resting ankle brachial index is known to have a sig-
niﬁcant limitation, especially in the setting of aor-
toiliac lesions (8). Furthermore, there was also a high
attrition rate of patients during the follow-up period.
Overall survival rates at 10- and 15-year follow-up
were mere 56% and 40%, respectively. As expected,
survival was worse in patients presenting with more
complex lesions (TASC II type C/D) with 10- and
15-year survival rates of 47% and 23%, respectively.
Although this leaves relatively fewer patients “at
risk” of analysis of patency at 15-year follow up
(n ¼ 15), the statistics are telling in terms of high level
of cardiovascular mortality in these patients.
Competing risk analyses would likely yield greater
insight into the statistical validity of patency com-
parisons among the different subgroups in the face of
high attrition rates due to mortality.
Although the current study has many limitations
inherent in a retrospective cohort study over a
15-year interval, 2 points require further attention.
First, there was a considerably lower use of aspirin
(69%), thienopyridine (36%), and statin (35%) thera-
pies, with mean low-density lipoprotein cholesterol
of 118 mg/dl, which is reﬂective of suboptimal control
of hyperlipidemia in this high-risk population for
future cardiovascular events. Although the impact of
aggressive risk factor modiﬁcation on long-term
patency is controversial, there is little doubt that
lipid lowering, smoking cessation, and anti-
platelet therapy will reduce major adverse cardio-
vascular events in this population (1). Second,Kumakura et al. (7) provided data to demonstrate the
utility of adjunctive imaging in peripheral vascular
interventions. To date, endovascular revasculariza-
tion has been performed using angiography alone,
with little contribution of adjunctive modalities such
as IVUS, optical coherence tomography, or fractional
ﬂow reserve (FFR), which are routinely used for
coronary interventions. Hitchner et al. (9) demon-
strated that IVUS evaluation provided more accurate
intraprocedural insight on the extent of residual
stenosis after superﬁcial femoral artery in-
terventions, using a cohort of 59 patients. Similarly,
small studies have demonstrated the utility of
endovascular hemodynamic pressure wire assess-
ment in lower extremities (10–12).
We have learned several concepts from the
assessment of coronary artery lesions that can and
should be successfully applied to peripheral arteries.
Visual estimation of stenoses has been shown to be
imprecise in the coronary arteries (13,14). FFR-guided
percutaneous coronary intervention (PCI) has been
associated with improved outcomes with judicious
use of stents and similar relief of ischemia compared
with angiography-guided PCI (15). Similar to FFR-
guided interventions, IVUS-guided PCI has been also
associated with improved mortality as well as target
vessel revascularization compared with angiography-
guided PCI alone (16,17). Recently, there have been
nationwide concerns raised regarding the appropri-
ateness of PAD interventions in several large clinical
practices, leading to heightened scrutiny of these
procedures (18). This underscores the importance of
adjunctive imaging such as IVUS or FFR to determine
the “appropriateness” of interventions and allow
objective assessment of peripheral interventions to
gain better patency and outcomes (18).
Treatment of lower extremity PAD continues to
evolve with better diagnostic tools, equipment
advances, and increased operator experience. The
Affordable Care Act and higher emphasis on quality
rather than quantity should support the use of
adjunctive tools to make peripheral interventions
more accurate, safer, and better.
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